Time-to-Event analysis: beyond survival curves
Jesca Birungi
Biostatistician | helping healthcare professionals and scientists understand hidden insights in complex healthcare data | Open to PHD and research opportunities in Biostatistics
Time-to-event analysis, , is a statistical method used to examine the time until a particular event occurs. While survival curves, such as those produced by the Kaplan-Meier estimator, are fundamental tools in this field, there are advanced methods designed to address more complex scenarios. This article will look into some of these advanced methods, focusing on recurrence data and interval-censored data.
1. Recurrence data
Recurrence data involves situations where the event of interest can happen multiple times for the same subject. For instance, in clinical trials, a patient might experience multiple episodes of a disease or multiple relapses. Analyzing recurrence data requires methods that account for the repeated nature of the events.
Key Methods:
Example: In a study of cancer patients, recurrence data might be analyzed to determine the time between relapses and the impact of various treatments on recurrence rates.
2. Interval-Censored Data
Interval-censored data occurs when the exact time of an event is not known but is known to fall within a certain time interval. For example, if a patient's follow-up visit is scheduled every six months, the exact time of disease progression may only be known to fall within that six-month period.
领英推荐
Key Methods:
Example: In a study of disease progression where patients are seen at regular intervals, interval-censored data analysis can provide insights into the timing of disease progression despite the lack of precise event times.
3. When to Use Which
Conclusion
Time-to-event analysis involves more than just survival curves. Advanced methods like those for recurrence data and interval-censored data allow researchers to handle complex scenarios and draw more accurate conclusions from their data. Understanding and applying these methods is crucial for a comprehensive analysis of time-to-event data in various fields, including clinical trials, epidemiology, and reliability engineering.
Clinical Trials Biostatistician at 2KMM (100% R-based CRO) ? Frequentist (non-Bayesian) paradigm ? NOT a Data Scientist (no ML/AI), no SAS ? Against anti-car/-meat/-cash restrictions ? In memory of The Volhynian Mаssасrе
2 个月It's so refreshing to see something else than KM and Cox, mangles over and over! I will only add that the frailty and multi-state models can be extended also for terminal events (kind of competing risks), like death. In this case we have the joint-frailty (rather than shared-frailty) model.